Reading of 3 mins 
Natac Group (NAT), a biotechnology company specialized in the sustainable production of botanical extracts and omega-3 oils with proven health benefits, closed 2024 with record sales and EBITDA, further consolidating its position as one of the leaders in the natural and healthy ingredients industry.
Specifically, the group’s revenue reached €35.85 million, representing a 35% increase over the previous year. Product sales accounted for most of the income, exceeding €34.7 million, representing a 52% increase. Meanwhile, normalized EBITDA reached €13.82 million, up 47% from the prior year. However, net profit for 2024 was significantly lower than the previous year due to the impact of the acquisition of IFFE Group’s Omega 3 factory completed in 2023.
Strong performance across all business segments drove revenue and EBITDA growth, with a notable highlight being the animal nutrition division, which grew by 121% in 2024. Additionally, operational optimization and acquiring more than 80 new clients from strategic markets such as Italy, France, Germany, and Spain contributed significantly to these results.
According to Antonio Delgado, CEO of Natac, “the results achieved in 2024 reflect the strength of our business model and the effectiveness of our growth strategy. We will continue working to solidify Natac’s leadership in the natural ingredients sector while exploring new opportunities in key markets.”
Key Milestones of 2024
In 2024, the company obtained GMP quality certification, allowing it to manufacture APIs (Active Pharmaceutical Ingredients) for the pharmaceutical sector. This certification enables Natac to diversify its product portfolio while expanding its national and international client base, effectively doubling its target market.
Another important milestone was the start-up of the Omega 3 factory in As Somozas, the largest in Spain. This production plant refines, deodorizes, and bleaches omega-3 fish oils and develops innovative ingredients for the food, nutraceutical, and animal nutrition sectors. After completing production trials, the facility began operations in mid-September. Recently, Innovaoleo, Natac’s Omega 3 division, launched Omega 3 Star, a premium oil that stands out in the market for its neutral taste, smell, and color.
Outlook for 2025 and 2026
Both API manufacturing and omega-3 production will serve as major growth drivers for the company, which will focus on organic growth by expanding its customer base and strengthening its presence in high-potential markets such as the United Kingdom, Latin America, and the Middle East. Although not included in the current business plan, Natac remains open to evaluating potential corporate operations should the right opportunity arise.
The company expects to close 2025 with revenues of over 55 million euros and a normalized EBITDA of over 20 million euros, while the guidance for 2026 calls for revenues and a normalized EBITDA of over 68 million euros and 26 million euros, respectively.
